Information Provided By: 
Fly News Breaks for December 4, 2015
TEVA
Dec 4, 2015 | 08:12 EDT
As previously reported, Guggenheim upgraded Teva to Buy from Neutral and established an $80 price target on shares. Analyst Louise Chen said the recent capital raise removes an overhang and believes upward earnings revisions and multiple expansion will drive shares higher. Chen named Teva a new Best Idea.
News For TEVA From the Last 2 Days
There are no results for your query TEVA
